 | • レポートコード：MRC2012B0783 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ミクロビオーム医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。ミクロビオーム医薬品の種類別市場規模（プロバイオティクス、プレバイオティクス、小分子、生物製剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Rebiotix、MaaT Pharma、Second Genome、Ritter Pharmaceuticals、Seres Therapeutics、MicroBiome Therapeutics、Enterome Bioscience、OpenBiome、 ・地域別グローバル市場分析 2015年-2020年 ・ミクロビオーム医薬品の北米市場（アメリカ、カナダ、メキシコ） ・ミクロビオーム医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ミクロビオーム医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ミクロビオーム医薬品の南米市場（ブラジル、アルゼンチン） ・ミクロビオーム医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロバイオティクス、プレバイオティクス、小分子、生物製剤、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Microbiome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Microbiome Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Microbiome Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Microbiome Drugs market has been segmented into:
Probiotics
Prebiotics
Small Molecules
Biological Drugs
Other
By Application, Microbiome Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Microbiome Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Microbiome Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Microbiome Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Microbiome Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Microbiome Drugs Market Share Analysis
Microbiome Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Microbiome Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Microbiome Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Microbiome Drugs are:
Pfizer
Rebiotix
MaaT Pharma
Second Genome
Ritter Pharmaceuticals
Seres Therapeutics
MicroBiome Therapeutics
Enterome Bioscience
OpenBiome
Table of Contents
1 Microbiome Drugs Market Overview
1.1 Product Overview and Scope of Microbiome Drugs
1.2 Classification of Microbiome Drugs by Type
1.2.1 Global Microbiome Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Microbiome Drugs Revenue Market Share by Type in 2019
1.2.3 Probiotics
1.2.4 Prebiotics
1.2.5 Small Molecules
1.2.6 Biological Drugs
1.2.7 Other
1.3 Global Microbiome Drugs Market by Application
1.3.1 Overview: Global Microbiome Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Global Microbiome Drugs Market by Regions
1.4.1 Global Microbiome Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Microbiome Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Microbiome Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Microbiome Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Microbiome Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Microbiome Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Microbiome Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Rebiotix
2.2.1 Rebiotix Details
2.2.2 Rebiotix Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Rebiotix SWOT Analysis
2.2.4 Rebiotix Product and Services
2.2.5 Rebiotix Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 MaaT Pharma
2.3.1 MaaT Pharma Details
2.3.2 MaaT Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 MaaT Pharma SWOT Analysis
2.3.4 MaaT Pharma Product and Services
2.3.5 MaaT Pharma Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Second Genome
2.4.1 Second Genome Details
2.4.2 Second Genome Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Second Genome SWOT Analysis
2.4.4 Second Genome Product and Services
2.4.5 Second Genome Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ritter Pharmaceuticals
2.5.1 Ritter Pharmaceuticals Details
2.5.2 Ritter Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ritter Pharmaceuticals SWOT Analysis
2.5.4 Ritter Pharmaceuticals Product and Services
2.5.5 Ritter Pharmaceuticals Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Seres Therapeutics
2.6.1 Seres Therapeutics Details
2.6.2 Seres Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Seres Therapeutics SWOT Analysis
2.6.4 Seres Therapeutics Product and Services
2.6.5 Seres Therapeutics Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 MicroBiome Therapeutics
2.7.1 MicroBiome Therapeutics Details
2.7.2 MicroBiome Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 MicroBiome Therapeutics SWOT Analysis
2.7.4 MicroBiome Therapeutics Product and Services
2.7.5 MicroBiome Therapeutics Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Enterome Bioscience
2.8.1 Enterome Bioscience Details
2.8.2 Enterome Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Enterome Bioscience SWOT Analysis
2.8.4 Enterome Bioscience Product and Services
2.8.5 Enterome Bioscience Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 OpenBiome
2.9.1 OpenBiome Details
2.9.2 OpenBiome Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 OpenBiome SWOT Analysis
2.9.4 OpenBiome Product and Services
2.9.5 OpenBiome Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Microbiome Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Microbiome Drugs Players Market Share
3.2.2 Top 10 Microbiome Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Microbiome Drugs Revenue and Market Share by Regions
4.2 North America Microbiome Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Microbiome Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Microbiome Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Microbiome Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Microbiome Drugs Revenue and Growth Rate (2015-2020)
5 North America Microbiome Drugs Revenue by Countries
5.1 North America Microbiome Drugs Revenue by Countries (2015-2020)
5.2 USA Microbiome Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Microbiome Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Microbiome Drugs Revenue and Growth Rate (2015-2020)
6 Europe Microbiome Drugs Revenue by Countries
6.1 Europe Microbiome Drugs Revenue by Countries (2015-2020)
6.2 Germany Microbiome Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Microbiome Drugs Revenue and Growth Rate (2015-2020)
6.4 France Microbiome Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Microbiome Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Microbiome Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Microbiome Drugs Revenue by Countries
7.1 Asia-Pacific Microbiome Drugs Revenue by Countries (2015-2020)
7.2 China Microbiome Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Microbiome Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Microbiome Drugs Revenue and Growth Rate (2015-2020)
7.5 India Microbiome Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Microbiome Drugs Revenue and Growth Rate (2015-2020)
8 South America Microbiome Drugs Revenue by Countries
8.1 South America Microbiome Drugs Revenue by Countries (2015-2020)
8.2 Brazil Microbiome Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Microbiome Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Microbiome Drugs by Countries
9.1 Middle East & Africa Microbiome Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Microbiome Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Microbiome Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Microbiome Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Microbiome Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Microbiome Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Microbiome Drugs Market Forecast by Type (2019-2024)
10.3 Probiotics Revenue Growth Rate (2015-2025)
10.4 Prebiotics Revenue Growth Rate (2015-2025)
10.5 Small Molecules Revenue Growth Rate (2015-2025)
10.6 Biological Drugs Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Microbiome Drugs Market Segment by Application
11.1 Global Microbiome Drugs Revenue Market Share by Application (2015-2020)
11.2 Microbiome Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Microbiome Drugs Market Size Forecast (2021-2025)
12.1 Global Microbiome Drugs Market Size Forecast (2021-2025)
12.2 Global Microbiome Drugs Market Forecast by Regions (2021-2025)
12.3 North America Microbiome Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Microbiome Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Microbiome Drugs Revenue Market Forecast (2021-2025)
12.6 South America Microbiome Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Microbiome Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Microbiome Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Microbiome Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Microbiome Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Microbiome Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Microbiome Drugs Major Business
Table 7. Pfizer Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Microbiome Drugs Product and Solutions
Table 10. Pfizer Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Rebiotix Corporate Information, Location and Competitors
Table 12. Rebiotix Microbiome Drugs Major Business
Table 13. Rebiotix Microbiome Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Rebiotix SWOT Analysis
Table 15. Rebiotix Microbiome Drugs Product and Solutions
Table 16. Rebiotix Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. MaaT Pharma Corporate Information, Location and Competitors
Table 18. MaaT Pharma Microbiome Drugs Major Business
Table 19. MaaT Pharma Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 20. MaaT Pharma SWOT Analysis
Table 21. MaaT Pharma Microbiome Drugs Product and Solutions
Table 22. MaaT Pharma Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Second Genome Corporate Information, Location and Competitors
Table 24. Second Genome Microbiome Drugs Major Business
Table 25. Second Genome Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Second Genome SWOT Analysis
Table 27. Second Genome Microbiome Drugs Product and Solutions
Table 28. Second Genome Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ritter Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Ritter Pharmaceuticals Microbiome Drugs Major Business
Table 31. Ritter Pharmaceuticals Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Ritter Pharmaceuticals SWOT Analysis
Table 33. Ritter Pharmaceuticals Microbiome Drugs Product and Solutions
Table 34. Ritter Pharmaceuticals Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Seres Therapeutics Corporate Information, Location and Competitors
Table 36. Seres Therapeutics Microbiome Drugs Major Business
Table 37. Seres Therapeutics Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Seres Therapeutics SWOT Analysis
Table 39. Seres Therapeutics Microbiome Drugs Product and Solutions
Table 40. Seres Therapeutics Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. MicroBiome Therapeutics Corporate Information, Location and Competitors
Table 42. MicroBiome Therapeutics Microbiome Drugs Major Business
Table 43. MicroBiome Therapeutics Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 44. MicroBiome Therapeutics SWOT Analysis
Table 45. MicroBiome Therapeutics Microbiome Drugs Product and Solutions
Table 46. MicroBiome Therapeutics Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Enterome Bioscience Corporate Information, Location and Competitors
Table 48. Enterome Bioscience Microbiome Drugs Major Business
Table 49. Enterome Bioscience Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Enterome Bioscience SWOT Analysis
Table 51. Enterome Bioscience Microbiome Drugs Product and Solutions
Table 52. Enterome Bioscience Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. OpenBiome Corporate Information, Location and Competitors
Table 54. OpenBiome Microbiome Drugs Major Business
Table 55. OpenBiome Microbiome Drugs Total Revenue (USD Million) (2017-2018)
Table 56. OpenBiome SWOT Analysis
Table 57. OpenBiome Microbiome Drugs Product and Solutions
Table 58. OpenBiome Microbiome Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Microbiome Drugs Revenue (Million USD) by Players (2015-2020)
Table 60. Global Microbiome Drugs Revenue Share by Players (2015-2020)
Table 61. Global Microbiome Drugs Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Microbiome Drugs Revenue Market Share by Regions (2015-2020)
Table 63. North America Microbiome Drugs Revenue by Countries (2015-2020)
Table 64. North America Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Table 65. Europe Microbiome Drugs Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Microbiome Drugs Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Microbiome Drugs Revenue by Countries (2015-2020)
Table 68. South America Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Microbiome Drugs Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Global Microbiome Drugs Revenue (Million USD) by Type (2015-2020)
Table 72. Global Microbiome Drugs Revenue Share by Type (2015-2020)
Table 73. Global Microbiome Drugs Revenue Forecast by Type (2021-2025)
Table 74. Global Microbiome Drugs Revenue by Application (2015-2020)
Table 75. Global Microbiome Drugs Revenue Share by Application (2015-2020)
Table 76. Global Microbiome Drugs Revenue Forecast by Application (2021-2025)
Table 77. Global Microbiome Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Microbiome Drugs Picture
Figure 2. Global Microbiome Drugs Revenue Market Share by Type in 2019
Figure 3. Probiotics Picture
Figure 4. Prebiotics Picture
Figure 5. Small Molecules Picture
Figure 6. Biological Drugs Picture
Figure 7. Other Picture
Figure 8. Microbiome Drugs Revenue Market Share by Application in 2019
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Other Picture
Figure 13. Global Microbiome Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Microbiome Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Microbiome Drugs Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Microbiome Drugs Revenue Market Share in 2019
Figure 22. Global Top 10 Players Microbiome Drugs Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Microbiome Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Microbiome Drugs Revenue Market Share by Regions (2015-2020)
Figure 26. Global Microbiome Drugs Revenue Market Share by Regions in 2018
Figure 27. North America Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Europe Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 30. South America Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 32. North America Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. North America Microbiome Drugs Revenue Market Share by Countries in 2019
Figure 34. USA Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Canada Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Europe Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Microbiome Drugs Revenue Market Share by Countries in 2019
Figure 39. Germany Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 40. UK Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 41. France Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Russia Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Italy Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Microbiome Drugs Revenue Market Share by Countries in 2019
Figure 46. China Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Japan Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Korea Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 49. India Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 51. South America Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. South America Microbiome Drugs Revenue Market Share by Countries in 2019
Figure 53. Brazil Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Microbiome Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Microbiome Drugs Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 58. UAE Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Microbiome Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Global Microbiome Drugs Revenue Share by Type (2015-2020)
Figure 62. Global Microbiome Drugs Revenue Share by Type in 2019
Figure 63. Global Microbiome Drugs Market Share Forecast by Type (2021-2025)
Figure 64. Global Probiotics Revenue Growth Rate (2015-2020)
Figure 65. Global Prebiotics Revenue Growth Rate (2015-2020)
Figure 66. Global Small Molecules Revenue Growth Rate (2015-2020)
Figure 67. Global Biological Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Other Revenue Growth Rate (2015-2020)
Figure 69. Global Microbiome Drugs Revenue Share by Application (2015-2020)
Figure 70. Global Microbiome Drugs Revenue Share by Application in 2019
Figure 71. Global Microbiome Drugs Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Microbiome Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Microbiome Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Microbiome Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Microbiome Drugs Revenue Market Forecast (2021-2025)
Figure 80. Europe Microbiome Drugs Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Microbiome Drugs Revenue Market Forecast (2021-2025)
Figure 82. South America Microbiome Drugs Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Microbiome Drugs Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
ヒトマイクロバイオームベース薬剤・診断の世界市場（～2026年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…- ヒトマイクロバイオーム治療薬の世界市場（～2026年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…
- ヒトマイクロバイオームの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Human Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…